Key result
Neither HTLV-I nor HFV DNA sequences were detected in any thymoma tissues, and serological testing found no evidence of HTLV-I/II infection in US thymoma patients.
Why the study?
Is there evidence of HTLV-I or HFV infection in US patients with thymoma?
Case-Control (n=61)
No
Is there evidence of HTLV-I or HFV infection in US patients with thymoma?
This study found no evidence supporting an etiologic role for HTLV-I or HFV in US patients with thymoma.
No HTLV-I/HFV evidence in US thymoma; leaves open alternative etiologies for investigation.
The cause of thymoma, a rare malignancy of thymic epithelial cells, is unknown. Recent studies have reported the detection of DNA from human T-cell lymphotropic virus type I (HTLV-I) and human foamy virus (HFV) in small numbers of thymoma tumours, suggesting an aetiologic role for these retroviruses. In the present study, we evaluated 21 US thymoma patients and 20 patients with other cancers for evidence of infection with these viruses. We used the polymerase chain reaction to attempt to amplify viral DNA from tumour tissues, using primers from the pol and tax (HTLV-I) and gag and bel1 (HFV) regions. In these experiments, we did not detect HTLV-I or HFV DNA sequences in any thymoma or control tissues, despite adequate sensitivity of our assays (one HTLV-I copy per 25 000 cells, one HFV copy per 7500 cells). Additionally, none of 14 thymoma patients evaluated serologically for HTLV I/II infection was positive by enzyme-linked immunoassay (ELISA), while five (36%) had indeterminate Western blot reactivity. In comparison, one of 20 US blood donors was HTLV-I/II ELISA positive, and nine (45%) donors, including the ELISA-positive donor, had indeterminate Western blot reactivity. Western blot patterns varied across individuals and consisted mostly of weak reactivity. In conclusion, we did not find evidence for the presence of HTLV-I or HFV in US thymoma patients.
No takes yet. Share an insight, caveat, or question.
Li et al. (2004) conducted a case-control in Thymoma (n=61). HTLV-I and HFV infection vs. Patients with other cancers and healthy blood donors was evaluated on Detection of HTLV-I and HFV DNA sequences in tumor tissues by PCR. Neither HTLV-I nor HFV DNA sequences were detected in any thymoma tissues, and serological testing found no evidence of HTLV-I/II infection in US thymoma patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: